news about meb
March 19, 2013 - Public consultation MEB Strategic Business Plan 2014-2018
The Medicines Evaluation Board (MEB) has made its draft Strategic Business Plan (SBP) 2014 – 2018 open for public consultation until 31 March 2013.
This SBP will determine the direction of the organisation for the next five years and will form the basis of the annual plans by the MEB. The annual reports by the MEB will provide a progress report on the SBP. The new SBP is partly a continuation of the strategy set out over the past years, but important sections will be intensified and new directions will be taken.
The new SBP has been submitted to the Minister of Health, Welfare and Sport for final approval. The MEB’s new Strategic Business Plan will be presented at the MEB Day on 5 June 2013.
Go back Overview »